Tom has approximately 30 years of experience in intellectual property law. Tom handles patent prosecution, licensing, litigation, and appeals. Tom has also served as an expert witness on patent and licensing matters in cases involving patent infringement, antitrust, licensing, and legal malpractice.

Prior to starting his own firm, Tom was vice president and head of the US patent and trademark department for Novartis, one of the world’s largest branded and generic pharmaceutical companies. Tom held a variety of positions during his years at Novartis, including global head of intellectual property litigation for Novartis’s branded and generic pharmaceuticals and consumer businesses, deputy global head of pharmaceutical patents, head of Novartis’s agricultural biotechnology patent group in North Carolina, and pharmaceutical patent attorney at Sandoz (a predecessor company to Novartis) in Basel, Switzerland. Prior to going in-house, Tom was a litigation attorney in private practice in Baltimore and Washington, D.C., and has been lead counsel on a number of jury and bench trials. Tom has given numerous seminars on patent law to patent attorneys in the United States and Europe, he was a tutor in European patent law for the Centre d’Etudes Internationales de la Propriété Industrielle (CEIPI), Université de Strasbourg, Strasbourg, France, and he is a co-author of “Patents for Chemicals, Pharmaceuticals, and Biotechnology”, 6th ed., 2016, Oxford University Press.

Tom is a registered patent attorney and a member of the New Jersey, Maryland and District of Columbia bars. Tom also passed the European Patent Attorney qualifying examination and was admitted as a solicitor in England and Wales, although he does not currently maintain a practice in Europe. Tom has a B.S. and a J.D. with honors, both from the University of Maryland.